DNA rearrangements in human follicular lymphoma can involve the 5' or the 3' region of the bcl-2 gene - PubMed (original) (raw)

DNA rearrangements in human follicular lymphoma can involve the 5' or the 3' region of the bcl-2 gene

Y Tsujimoto et al. Proc Natl Acad Sci U S A. 1987 Mar.

Abstract

In most human follicular lymphomas, the chromosome translocation t(14;18) occurs within two breakpoint clustering regions on chromosome 18, the major one at the 3' untranslated region of the bcl-2 gene and the minor one at 3' of the gene. Analysis of a panel of follicular lymphoma DNAs using probes for the first exon of the bcl-2 gene indicates that DNA rearrangements may also occur 5' to the involved bcl-2 gene. In this case the IgH locus and the bcl-2 gene are found in the order 3' C gamma S gamma/mu JH 5'::5' bcl-2 3' (where C = constant, S = switch, and JH = joining segment of the heavy chain locus), suggesting that an inversion also occurred during the translocation process. The coding regions of the bcl-2 gene, however, are left intact in all cases of follicular lymphoma studied to date.

PubMed Disclaimer

Similar articles

• Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
  Limpens J, de Jong D, van Krieken JH, Price CG, Young BD, van Ommen GJ, Kluin PM. Limpens J, et al. Oncogene. 1991 Dec;6(12):2271-6. Oncogene. 1991. PMID: 1766674
• bcl-2 gene rearrangement analysis of Japanese follicular lymphomas by polymerase chain reaction in formalin-fixed, paraffin-embedded tissue specimens.
  Mitani S, Aoki N, Mizutani S, Fujiwara M, Kitagawa T, Uehara T, Mori S. Mitani S, et al. Jpn J Cancer Res. 1993 Jan;84(1):37-41. doi: 10.1111/j.1349-7006.1993.tb02781.x. Jpn J Cancer Res. 1993. PMID: 8449825 Free PMC article.
• A submicroscopic interstitial deletion of chromosome 14 frequently occurs adjacent to the t(14;18) translocation breakpoint in human follicular lymphoma.
  Zelenetz AD, Cleary ML, Levy R. Zelenetz AD, et al. Genes Chromosomes Cancer. 1993 Mar;6(3):140-50. doi: 10.1002/gcc.2870060303. Genes Chromosomes Cancer. 1993. PMID: 7682098
• Molecular mechanism of the t(14;18)--a model for lymphoid-specific chromosomal translocations.
  Jaeger U, Karth GD, Knapp S, Friedl J, Laczika K, Kusec R. Jaeger U, et al. Leuk Lymphoma. 1994 Jul;14(3-4):197-202. doi: 10.3109/10428199409049669. Leuk Lymphoma. 1994. PMID: 7950908 Review.
• t(2;18) and t(18;22) variant chromosomal translocations and bcl-2 gene rearrangements in human malignant lymphomas.
  Larsen CJ, Mecucci C, Leroux D. Larsen CJ, et al. Nouv Rev Fr Hematol (1978). 1990;32(6):401-3. Nouv Rev Fr Hematol (1978). 1990. PMID: 2129304 Review.

Cited by

• Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies.
  Constantinescu C, Pasca S, Zimta AA, Tat T, Rus I, Teodorescu P, Iluta S, Tanase A, Colita A, Sigurjonsson O, Einsele H, Tomuleasa C. Constantinescu C, et al. J Clin Med. 2020 Sep 8;9(9):2903. doi: 10.3390/jcm9092903. J Clin Med. 2020. PMID: 32911829 Free PMC article.
• Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide.
  Rodrigueza WV, Woolliscroft MJ, Ebrahim AS, Forgey R, McGovren PJ, Endert G, Wagner A, Holewa D, Aboukameel A, Gill RD, Bisgaier CL, Messmann RA, Whitehead CE, Izbicka E, Streeper R, Wick MC, Stiegler G, Stein CA, Monsma D, Webb C, Sooch MP, Panzner S, Mohammad R, Goodwin NC, Al-Katib A. Rodrigueza WV, et al. Cancer Chemother Pharmacol. 2014 Jul;74(1):151-66. doi: 10.1007/s00280-014-2476-y. Epub 2014 May 16. Cancer Chemother Pharmacol. 2014. PMID: 24832107 Free PMC article.
• A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma.
  Horvilleur E, Sbarrato T, Hill K, Spriggs RV, Screen M, Goodrem PJ, Sawicka K, Chaplin LC, Touriol C, Packham G, Potter KN, Dirnhofer S, Tzankov A, Dyer MJ, Bushell M, MacFarlane M, Willis AE. Horvilleur E, et al. Leukemia. 2014 May;28(5):1092-102. doi: 10.1038/leu.2013.295. Epub 2013 Oct 18. Leukemia. 2014. PMID: 24135829 Free PMC article.
• Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas.
  Goteri G, Lucarini G, Zizzi A, Costagliola A, Giantomassi F, Stramazzotti D, Rubini C, Leoni P. Goteri G, et al. Diagn Pathol. 2011 Oct 11;6:97. doi: 10.1186/1746-1596-6-97. Diagn Pathol. 2011. PMID: 21988858 Free PMC article.
• Telomerase activity, estrogen receptors (alpha, beta), Bcl-2 expression in human breast cancer and treatment response.
  Murillo-Ortiz B, Astudillo-De la Vega H, Castillo-Medina S, Malacara JM, Benitez-Bribiesca L. Murillo-Ortiz B, et al. BMC Cancer. 2006 Aug 15;6:206. doi: 10.1186/1471-2407-6-206. BMC Cancer. 2006. PMID: 16911782 Free PMC article. Clinical Trial.

References

1. 1. J Mol Biol. 1975 Nov 5;98(3):503-17 - PubMed
2. 1. Cell. 1981 Dec;27(3 Pt 2):583-91 - PubMed
3. 1. Cancer Res. 1979 Aug;39(8):3119-28 - PubMed
4. 1. N Engl J Med. 1982 Nov 11;307(20):1231-6 - PubMed
5. 1. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5611-5 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program